2020
DOI: 10.3390/ijms21239189
|View full text |Cite
|
Sign up to set email alerts
|

PTEN and Other PtdIns(3,4,5)P3 Lipid Phosphatases in Breast Cancer

Abstract: The phosphoinositide 3-kinase (PI3K)/AKT signalling pathway is hyperactivated in ~70% of breast cancers. Class I PI3K generates PtdIns(3,4,5)P3 at the plasma membrane in response to growth factor stimulation, leading to AKT activation to drive cell proliferation, survival and migration. PTEN negatively regulates PI3K/AKT signalling by dephosphorylating PtdIns(3,4,5)P3 to form PtdIns(4,5)P2. PtdIns(3,4,5)P3 can also be hydrolysed by the inositol polyphosphate 5-phosphatases (5-phosphatases) to produce PtdIns(3,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
35
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(39 citation statements)
references
References 145 publications
0
35
0
Order By: Relevance
“…Hence PI3K/Akt signaling appears to be a target of Ltp1, but acting through an inhibitor to cause increased phosphorylation. The phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase (PTEN) preferentially dephosphorylates phosphoinositide substrates and thus inhibits PI3K action by negatively regulating intracellular levels of phosphatidylinositol-3,4,5-trisphosphate [ 67 ]. Several lines of evidence indicated that dephosphorylation of PTEN by Ltp1 increases proteasomal degradation, thus relieving suppression of PI3K/Akt.…”
Section: Discussionmentioning
confidence: 99%
“…Hence PI3K/Akt signaling appears to be a target of Ltp1, but acting through an inhibitor to cause increased phosphorylation. The phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase (PTEN) preferentially dephosphorylates phosphoinositide substrates and thus inhibits PI3K action by negatively regulating intracellular levels of phosphatidylinositol-3,4,5-trisphosphate [ 67 ]. Several lines of evidence indicated that dephosphorylation of PTEN by Ltp1 increases proteasomal degradation, thus relieving suppression of PI3K/Akt.…”
Section: Discussionmentioning
confidence: 99%
“…In gliomas, miR-492-3p negatively regulates the expression of PTEN, whereas circNALCN positively regulates the expression of PTEN. Previous studies have shown that PTEN acts as a tumor suppressor in most human tumors, such as pancreatic cancer, HCC, and breast cancer [ 32 34 ]. Decreased PTEN expression is typically associated with aggressive tumors and a worse prognosis.…”
Section: Discussionmentioning
confidence: 99%
“…GUCY2C, which encodes the guanylate cyclase C receptor, is known to reduce stem cell vulnerability to environmental damage by modulating the endoplasmic reticulum stress response ( Kraft et al, 2017 ). SYNJ2 (Synaptojanin 2) has been identified as a player in epidermal growth factor receptor (EGFR) recycling and EGF-dependent migration ( Csolle et al, 2020 ). ANKRD13B codes for a member of the Ankyrin repeat domain-containing protein 13 family and has recently been described as interfering with regulation of the endosome-to-lysosome trafficking of Caveolin 1 (Cav-1) ( Burana et al, 2016 ).…”
Section: Discussionmentioning
confidence: 99%